Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for TreatingEnterococcus faecalisInfective Endocarditis
Author(s) -
Núria Fernández-Hidalgo,
Benito Almirante,
Joan Gavaldà,
Mercè Gurguí,
Carmen Peña,
Arístides de Alarcón,
Josefa Ruiz,
Isidre Vilacosta,
Miguel Montejo,
Núria Vallejo,
Francisco LópezMedrano,
Antonio Pláta Ciézar,
Javier López,
Carmen Hidalgo-Tenorio,
Juan Gálvez-Acebal,
Carmen Sáez,
José Manuel Lomas,
Marco Falcone,
Javier de la Torre,
Xavier Martínez-Lacasa,
Albert Pahissa
Publication year - 2013
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cit052
Subject(s) - medicine , infective endocarditis , ceftriaxone , ampicillin , enterococcus faecalis , endocarditis , gentamicin , adverse effect , antibiotics , gastroenterology , surgery , staphylococcus aureus , microbiology and biotechnology , genetics , bacteria , biology
The aim of this study was to compare the effectiveness of the ampicillin plus ceftriaxone (AC) and ampicillin plus gentamicin (AG) combinations for treating Enterococcus faecalis infective endocarditis (EFIE).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom